StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$85.57+2.09 (+2.50%)

Close on Nov 18, 2026Market cap $35.36BP/E 14.1Yield 2.37%

Zoetis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Zoetis's revenue for the twelve months ending Jun 30, 2026 was $9.52B, up 1.5% year over year. For fiscal 2025 it was $9.47B, up 2.3% from the year before. Over ten years it grew 7.1% a year on average. The highest annual figure on record is $9.47B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.47B+2.3%
FY2024Dec 31, 2024$9.26B+8.3%
FY2023Dec 31, 2023$8.54B+5.7%
FY2022Dec 31, 2022$8.08B+3.9%
FY2021Dec 31, 2021$7.78B+16.5%
FY2020Dec 31, 2020$6.68B+6.6%
FY2019Dec 31, 2019$6.26B+7.5%
FY2018Dec 31, 2018$5.83B+9.8%
FY2017Dec 31, 2017$5.31B+8.6%
FY2016Dec 31, 2016$4.89B+2.6%
FY2015Dec 31, 2015$4.77B-0.4%
FY2014Dec 31, 2014$4.79B+4.9%
FY2013Dec 31, 2013$4.56B+5.2%
FY2012Dec 31, 2012$4.34B+2.4%
FY2011Dec 31, 2011$4.23B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.47B-0.2%
Q1 FY2026Mar 31, 2026$2.26B+2.9%
Q4 FY2025Dec 31, 2025$2.39B+3.0%
Q3 FY2025Sep 30, 2025$2.40B+0.5%
Q2 FY2025Jun 30, 2025$2.47B+4.8%
Q1 FY2025Mar 31, 2025$2.20B+0.4%
Q4 FY2024Dec 31, 2024$2.32B+4.7%
Q3 FY2024Sep 30, 2024$2.39B+11.0%
Q2 FY2024Jun 30, 2024$2.36B+8.3%
Q1 FY2024Mar 31, 2024$2.19B+9.5%
Q4 FY2023Dec 31, 2023$2.21B+8.5%
Q3 FY2023Sep 30, 2023$2.15B+7.4%
Q2 FY2023Jun 30, 2023$2.18B+6.2%
Q1 FY2023Mar 31, 2023$2.00B+0.7%
Q4 FY2022Dec 31, 2022$2.04B+3.7%
Q3 FY2022Sep 30, 2022$2.00B+0.6%
Q2 FY2022Jun 30, 2022$2.05B+5.3%
Q1 FY2022Mar 31, 2022$1.99B+6.1%
Q4 FY2021Dec 31, 2021$1.97B+8.9%
Q3 FY2021Sep 30, 2021$1.99B+11.4%
Q2 FY2021Jun 30, 2021$1.95B+25.8%
Q1 FY2021Mar 31, 2021$1.87B+22.0%
Q4 FY2020Dec 31, 2020$1.81B+7.9%
Q3 FY2020Sep 30, 2020$1.79B+12.8%
Q2 FY2020Jun 30, 2020$1.55B+0.1%
Q1 FY2020Mar 31, 2020$1.53B+5.4%
Q4 FY2019Dec 31, 2019$1.67B+7.0%
Q3 FY2019Sep 30, 2019$1.58B+7.0%
Q2 FY2019Jun 30, 2019$1.55B+9.3%
Q1 FY2019Mar 31, 2019$1.46B+6.5%
Q4 FY2018Dec 31, 2018$1.56B+7.1%
Q3 FY2018Sep 30, 2018$1.48B+9.9%
Q2 FY2018Jun 30, 2018$1.42B+11.5%
Q1 FY2018Mar 31, 2018$1.37B+11.0%
Q4 FY2017Dec 31, 2017$1.46B+14.3%
Q3 FY2017Oct 1, 2017$1.35B+8.5%
Q2 FY2017Jul 2, 2017$1.27B–
Q1 FY2017Apr 2, 2017$1.23B–
Q4 FY2016Dec 31, 2016$1.28B–
Q3 FY2016Oct 2, 2016$1.24B–

More Zoetis figures

See a number that looks wrong?